These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Miller JA; Dacey RG; Diringer MN Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647 [TBL] [Abstract][Full Text] [Related]
6. Cerebral vasospasm after subarachnoid hemorrhage: an update. Heros RC; Zervas NT; Varsos V Ann Neurol; 1983 Dec; 14(6):599-608. PubMed ID: 6651248 [TBL] [Abstract][Full Text] [Related]
7. [Intraventricular and intracerebral hemorrhage as complication of hemodynamic therapy for vasospasm after subarachnoid hemorrhage--analysis of 2 cases]. Ishiguro S; Kimura A; Munemoto S; Ikeda M; Shoin K No Shinkei Geka; 1985 Dec; 13(12):1343-7. PubMed ID: 2418382 [TBL] [Abstract][Full Text] [Related]
8. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms. Yamakami I; Isobe K; Yamaura A Neurosurgery; 1987 Sep; 21(3):303-9. PubMed ID: 3670573 [TBL] [Abstract][Full Text] [Related]
9. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Awad IA; Carter LP; Spetzler RF; Medina M; Williams FC Stroke; 1987; 18(2):365-72. PubMed ID: 3564092 [TBL] [Abstract][Full Text] [Related]
10. Induced hypertension and hypervolemia for treatment of cerebral vasospasm. Levy ML; Giannotta SL Neurosurg Clin N Am; 1990 Apr; 1(2):357-65. PubMed ID: 2136148 [TBL] [Abstract][Full Text] [Related]
11. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487 [TBL] [Abstract][Full Text] [Related]
16. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Thomas JE; Rosenwasser RH Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963 [TBL] [Abstract][Full Text] [Related]
17. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. Shimoda M; Oda S; Tsugane R; Sato O J Neurosurg; 1993 Mar; 78(3):423-9. PubMed ID: 8433144 [TBL] [Abstract][Full Text] [Related]
18. [Serious pitfalls which can be encountered in a course of hypertension-hypervolemia therapy for vasospasm]. Abe S; Wada T; Miyazaki Y; Kanki T; Hashimoto T; Nakamura N No Shinkei Geka; 1992 Apr; 20(4):357-65. PubMed ID: 1570056 [TBL] [Abstract][Full Text] [Related]
19. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Findlay JM; Macdonald RL; Weir BK Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740 [TBL] [Abstract][Full Text] [Related]
20. Use of the extracranial-intracranial arterial bypass in the management of refractory vasospasm: a case report. Rosenstein J; Batjer HH; Samson DS Neurosurgery; 1985 Sep; 17(3):474-9. PubMed ID: 4047359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]